🇺🇸 FDA
Patent

US 11649468

Targeted integration into the PPP1R12C locus

granted A61PA61P43/00

Quick answer

US patent 11649468 (Targeted integration into the PPP1R12C locus) held by Sangamo Therapeutics, Inc. expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P43/00